Bulletin
Investor Alert

Topics

Health and Human Services Department

Video

Justice Ruth Bader Ginsburg Dies at 87

  • Justice Ruth Bader Ginsburg Dies at 87 Justice Ruth Bader Ginsburg Dies at 87 5:18
2:54 p.m. May 7, 2021 - By Quentin Fottrell
Why are ‘Karens’ so angry? Such incidents have not gone away. Instead, they’ve become another depressingly ubiquitous feature of modern lifeSuch incidents have not gone away. Instead, they’ve become another depressingly ubiquitous feature of modern life.
3:52 a.m. April 9, 2021 - By Tomi Kilgore
Cruise stocks are rallying, in wake of Florida suing CDC, HHS to restart operationsShares of cruise operators rose in premarket trading Friday, as over how and when operations can resume. Carnival Corp.'s stock climbed 1.9%, Royal Caribbean Group shares gained 0.8% and Norwegian Cruise Line Holdings Ltd. advanced 1.1% ahead of the open, while futures for the S&P 500 edged up 0.2%. As the companies have urged the Centers for Disease Control and Prevention (CDC) to allow them to restart cruises from U.S. ports this summer, on Thursday to force the restart of cruises, which have been suspended for more than a year as a result of the COVID-19 pandemic. Late Thursday, Royal Caribbean disclosed it was , while saying it "strongly" believed that President Joe Biden's stated goal for society to reopen in time for Independence Day "is a realistic goal."
8:30 a.m. March 30, 2021 - By Victor Reklaitis
Biden rolls out additional responses to anti-Asian violencePresident Joe Biden is making additional moves to respond to this month's and other recent anti-Asian violence, the White House said Tuesday in a statement. The moves include expanding the mandate for a White House Initiative on Asian Americans and Pacific Islanders in order to combat anti-Asian bias and violence, as well as boosting funding for AAPI survivors of domestic violence and sexual assault, with the Department of Health and Human Services allocating $49.5 million from the American Rescue Plan to a new grant program. In addition, the moves include establishing a new COVID-19 Equity Task Force committee and setting up a Department of Justice initiative to address anti-Asian violence.
8:51 a.m. Jan. 7, 2021 - By Jaimy Lee
CDC to dispense $22 billion to states for COVID-19 vaccines, testingThe U.S. government said Wednesday that the Centers for Disease Control and Prevention will be giving about $22 billion in funding to states and territories to support COVID-19 testing and the vaccine rollout by Jan. 19. The funding comes from the Coronavirus Response and Relief Supplemental Appropriations Act. About $19 billion is intended to support testing, contact tracing, and surveillance activities, while $3 billion will be dispensed for vaccination activities, the Department of Health and Human Services said in a statement.
10:01 a.m. Dec. 28, 2020 - By Ciara Linnane
U.S. has had more than 19 million COVID-19 cases, and Fauci is getting worried about a post-holiday surge Relief as Trump signs relief bill and Novavax is starting a Phase 3 trial of its vaccine candidate in the U.S. and MexicoThe global tally for confirmed cases of the coronavirus-borne illness COVID-19 topped 81 million on Monday, while the U.S. case tally topped 19 million, and experts warned the next few weeks will be hard after many Americans traveled over the Christmas holiday.
5:31 a.m. Dec. 28, 2020 - By Ciara Linnane
Novavax starts Phase 3 COVID vaccine trial with plans to enroll 30,000 volunteers in U.S. and MexicoNovavax Inc. said Monday it is starting a late-stage trial of its COVID-19 vaccine candidate with plans to enroll up to 30,000 volunteers at about 115 sites in the U.S. and Mexico. The trial is being supported by partners of Operation Warp Speed, the federal government program that aims to quickly develop vaccines and therapies, including the Department of Defense and the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), and the Biomedical Advanced Research and Development Authority (BARDA), part of the U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response. Barda is providing up to $1.6 billion to fund the trial under a Department of Defense agreement. The trial will be randomized, placebo-controlled and will evaluate the efficacy of the treatment, called NVX-CoV2373, in patients aged 18 and older. Shares were slightly higher Monday, and have gained more than 3,000% in 2020 on hopes for the vaccine.
11:44 a.m. Dec. 14, 2020 - By Quentin Fottrell
As some hospitals near 90% capacity due to COVID-19, this map can tell you if your local hospital is almost full A new tool can help people assess the hospital-bed situation in their areaA new tool can help people assess the hospital-bed situation in their area.
10:22 a.m. Dec. 10, 2020 - By Ciara Linnane
U.S. sets record one-day death toll from coronavirus as FDA committee meets to review Pfizer–BioNTech vaccine FDA head says initial assessment is ‘this is a vaccine that does meet our criteria. ... But we do want to hear from the vaccine advisory committee.’The U.S. set fresh records for single-day fatalities from the coronavirus illness COVID-19 and hospitalizations, as a U.S. regulatory advisory committee gathered to offer its verdict on the vaccine developed by Pfizer Inc. and its German partner BioNTech SE.
3:18 a.m. Dec. 10, 2020 - By Ciara Linnane
Moderna doses first patients in Phase 2/3 study of COVID-19 vaccine in adolescents Moderna Inc. said Thursday it has dosed the first participants in a Phase 2/3 study of its COVID-19 vaccine candidate in adolescents aged 12 to less than 18. The study is being conducted in collaboration with Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services. The biotech is aiming to generate data in the spring of 2021 that will support the use of the vaccine in that age group, Chief Executive Stéphane Bancel said in a statement. The trial will be randomized and include a control group and the company is aiming to enroll 3,000 participants in the U.S. who will be monitored for 12 months after the second dose. Shares rose 1.5% in premarket trade, but have gained 701% in the year to date, while the SPDR S&P Biotech ETF has gained 44% and the S&P 500 has gained 13.7%.
10:26 a.m. Dec. 9, 2020 - By Ciara Linnane
U.S. coronavirus case tally climbs to 15 million from 14 million in just five days U.S. sets fresh record for COVID-19 hospitalizations; Angela Merkel pleads with Germans to limit gatherings during holidaysThe global case tally for the coronavirus illness COVID-19 climbed above 68 million on Wednesday and the U.S. tally rose above 15 million as the virus continued to race across the nation, filling hospitals with record numbers of patients
2:18 a.m. Dec. 7, 2020 - By Quentin Fottrell
Joe Biden’s pandemic plan: Restore Obamacare, mandatory masks, paid sick leave and free COVID-19 tests The President-elect said: ‘Dealing with the coronavirus pandemic is one of the most important battles our administration will face’The President-elect said: ‘Dealing with the coronavirus pandemic is one of the most important battles our administration will face.’
4:36 a.m. Dec. 4, 2020 - By Ciara Linnane
Moderna to provide Israel health ministry with additional 4 million doses of its COVID-19 vaccine candidateModerna Inc. said Friday it is amending its supply agreement with the Israeli health ministry and will provide an additional 4 million doses of its experimental COVID-19 vaccine mRNA-1273. The amendment brings the total number of doses secured by Israel to 6 million. The vaccine is currently awaiting review for an emergency use authorization in the U.S., and has been submitted for approval in Europe. The company has initiated the rolling regulatory review process with the Ministry of Health in Israel, it said in a statement. The vaccine has proven to have 94% efficacy in a preliminary analysis of a Phase 3 trial conducted on 196 cases. The trial involves more than 30,000 participants and is being conducted with the NIAID part of the NIH and the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services. Moderna is also working to scale up manufacturing and aims to deliver about 500 million doses a year and up to 1 billion doses a year starting in 2021. Shares were slightly lower premarket, but have gained 704% in the year to date, while the JSPDR S&P 500 Biotech ETF has gained 41% and the S&P 500 [ has gained 13%.
5:11 a.m. Dec. 1, 2020 - By Andrew Keshner
‘There’s a war on organizing, collective bargaining, unions and workers’: Biden wants to undo Trump executive orders on federal workers Federal unions challenged three Trump administration orders in particular. Federal unions challenged three Trump administration orders in particular.
2:50 a.m. Nov. 27, 2020 - By Jaimy Lee
COVID-19 cases and testing are surging as U.S. heads into Thanksgiving holiday In the week leading up to Thanksgiving, health care providers have reported rising numbers of people getting diagnostic tests, as some have sought out testing in advance of family dinners or travel plansA surge in the number of Americans testing positive for the coronavirus this month is worrying medical experts at the same time as the nation prepares for its first major indoor holiday during the COVID-19 pandemic.
10:55 a.m. Nov. 25, 2020 - By Ciara Linnane
Hospital workers called exhausted as U.S. records highest number of COVID deaths since May Parts of Europe are reporting declining cases and Sicily has asked Cuba to send doctors and nursesThe U.S. recorded the highest number of deaths from the coronavirus illness COVID-19 since May on Tuesday, and continues to average close to 200,000 new cases a day, with hospitals across the nation reporting exhausted health care workers and steadily filling intensive care units.
12:28 p.m. Nov. 24, 2020 - By Jaimy Lee
Rite Aid says it will continue to offer free COVID-19 tests in DecemberShares of Rite Aid Corp. were up 0.1% in after-hours trading on Tuesday after the drugstore chain confirmed that it will continue to offer no-charge COVID-19 testing in December. Rite Aid that it would begin charging $115 for symptomatic and asymptomatic diagnostic testing starting Dec. 1. The company currently does not charge people who come in for COVID-19 testing at its 301 testing sites. The Department of Health and Human Services said Rite Aid had notified HHS on Nov. 21 that it had conducted more tests than allocated in their contract, and that HHS had requested more funding for Rite Aid in response, according to a statement from Mia Heck, director of external affairs in the office of the assistant secretary for health. A Rite Aid spokesperson declined to comment beyond the news announcement. Rite Aid also on Tuesday announced plans to lower the age requirement for a COVID-19 test to 13 years old from 18 and said it plans to add 1,000 drive-through testing locations. All of the major drugstore chains in the U.S. including CVS Health Corp. and Walgreens Boots Alliance Inc. are offering coronavirus tests. Rite Aid's stock is down 28% so far this year, while the S&P 500 has gained 10.7%.
4:31 a.m. Nov. 24, 2020 - By Davide Mamone
It’s 2:30 a.m. in Wyoming: ‘You’re holding a smartphone to let a husband say goodbye to his wife via FaceTime after 60 years of marriage’ Doctors and nurses in North Dakota and Wyoming tell MarketWatch what it's like on the front lines of COVID-19Doctors and nurses in North Dakota and Wyoming tell MarketWatch what it's like on the front lines of COVID-19.
4:09 a.m. Nov. 24, 2020 - By Ciara Linnane
Rite Aid to start charging $115 per COVID-19 test from Dec. 1 as federal funding endsRite Aid Corp. said Tuesday it will start charging $115 per COVID-19 test from Dec. 1, following the end of federal funding for diagnostic testing by the U.S. Department of Health and Human Services. The drug store chain said it will offer testing for individuals aged 13 and older regardless of whether they are symptomatic or asymptomatic. Previously, it only offered testing to people aged 17 and up. The company is further planning to expand testing by adding another 1,000 drive-through locations. Rite Aid currently has 301 testing sites across 15 states. Shares rose 0.5% premarket, but are down 39% in the year to date, while the S&P 500 has gained 11%.
2:41 a.m. Nov. 17, 2020 - By Ciara Linnane
Moderna’s COVID-19 vaccine candidate sparks market rally after achieving 94.5% efficacy in late-stage trial and requires only standard refrigeration Biotech says vaccine remains stable at refrigerated temperatures for longer times, so distribution could be a lesser challengeModerna Inc. said Monday its COVID-19 vaccine candidate met its primary endpoint in a Phase 3 trial, demonstrating 94.5% efficacy, a far higher benchmark than originally expected, sparking a broad-based market rally.
3:51 a.m. Nov. 16, 2020 - By Ciara Linnane
UPDATE: Moderna shares soar premarket after COVID-19 vaccine candidate achieves 94.5% efficacy in Phase 3 trialModerna Inc. shares soared 16% in premarket trade Monday, after the biotech said its COVID-19 vaccine candidate met its primary endpoint in a Phase 3 trial, demonstrating 94.5% efficacy. The news was shared in a news release and has not yet been published as a preprint or in a peer-reviewed medical journal. The company said it plans to submit an Emergency Use Authorization with the U.S. Food and Drug Administration in the coming weeks and expects it to be based on the final analysis of 151 cases and a median follow-up for more than two months. The Phase 3 trial enrolled more than 30,000 participants in the U.S. and is being conducted with the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), and the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services. Moderna said the primary endpoint of the Phase 3 trial is based on the analysis of COVID-19 cases starting two weeks after the second dose of vaccine. The first analysis was based on 95 cases with 90 cases in the placebo group and 5 in the mRNA-1273 group. The 95 cases were in older adults, aged 65 years old and up, and 20 participants identifying as coming from diverse communities, with 12 Hispanic or LatinX, 4 Black or African-American, and 3 Asian Americans and 1 multi-racial person. The trial did not report any significant safety concerns. Last week, Pfizer INnc. and partner BioNTech SE said their vaccine candidate had achieved 90% efficacy in a Phase 3 trial, a far higher benchmark than originally expected. Shares have gained 357% in the year to date, while the S&P 500 has gained 11%.
9:47 a.m. Nov. 9, 2020 - By Quentin Fottrell
Joe Biden announces his COVID-19 task force The team of public-health experts will advise the Biden administration and the transition’s COVID-19 staffThe team of public-health experts will advise the Biden administration and the transition’s COVID-19 staff.
2:42 a.m. Nov. 9, 2020 - By Jaimy Lee
To defeat COVID-19, ‘we need a unified national strategy,’ says public health expert Dr. Howard Koh Koh served as assistant secretary of health during the H1N1 flu pandemic in 2009Dr. Howard Koh knows what it’s like to be a government official running a pandemic response.
2:02 a.m. Nov. 3, 2020 - By Ciara Linnane
Coronavirus update: Trump threatens to fire top infectious-disease expert Fauci as U.S. deaths top 231,000 The U.S. ‘could not be positioned more poorly’ for cold winter months, says Dr. Anthony Fauci, irking Trump and White HouseThe U.S. death toll from the coronavirus illness COVID-19 rose above 231,000 on Monday with cases rising in 42 states, as President Donald Trump continued to criticize a key infectious-disease expert and even hinted he might fire him if he wins Tuesday’s presidential election.
11:33 p.m. Nov. 1, 2020 - By Quentin Fottrell
Italy tightens COVID-19 restrictions, plunging Venice back into ‘victorious solitude’ Residents reflect on the pandemic and the costs of globalizationResidents reflect on the pandemic and the costs of globalization.
2:08 a.m. Oct. 22, 2020 - By Ciara Linnane
Coronavirus update: CDC says nearly 300,000 excess American deaths have occurred during pandemic CDC study finds biggest percentage rise in excess deaths were in those aged 25 to 44, Blacks and Hispanics hit disproportionatelyThe U.S. death toll from the coronavirus illness COVID-19 rose above 221,000 on Wednesday, according to data aggregated by Johns Hopkins University, and the nation’s leading public health agency estimated that the pandemic has contributed to the deaths of almost 300,000 Americans, including fatalities that would not have happened without the virus.
4:38 a.m. Oct. 14, 2020 - By Jaimy Lee
There are seven coronavirus vaccine candidates being tested in the U.S. — here’s where they stand At least four of the still investigational vaccines have moved into Phase 3 clinical trialsThe race to develop a safe and effective COVID-19 vaccine is well under way, setting the stage to bring to market the fastest vaccine in history.
9:12 p.m. Sept. 29, 2020 - By Quentin Fottrell
Can Trump write off $70K in haircuts? IRS allows tax deductions for highly unusual expenses — including fertility treatment, vasectomies and rehab The agency has guidelines on expenses that aim to ‘increase your personal prestige or establish your professional reputation’The agency has guidelines on expenses that aim to ‘increase your personal prestige or establish your professional reputation.’
10:57 a.m. Sept. 29, 2020 - By Ciara Linnane
Coronavirus update: Global case tally 33.4 million, death toll above 1 million, and that’s likely an underestimate, says WHO expert White House reportedly pressed the CDC to play down the risks of sending children back to school and sought alternate data that would show the coronavirus was unlikely to harm kidsThe number of confirmed cases of the coronavirus that causes COVID-19 rose to 33.4 million on Tuesday, a day after the global death toll reached 1 million, as governments around the world moved to reimpose restrictions on movement in a fight to contain the spread.
11:14 a.m. Sept. 25, 2020 - By Tomi Kilgore
Coronavirus update: U.S. cases top 7 million, after jumping by more than 45,000 in a single day Fiscal stimulus talks heat up as concerns grow over another COVID-19–related hit to the economy; Rio delays Carnival for the first time in a century, and Madrid calls for another shutdownA rising tide worldwide of new cases and deaths from the coronavirus that causes COVID-19 has prompted calls for new shutdown measures overseas and accountability in the U.S., but also renewed attempts at a stimulus bill to fend of another pandemic-induced economic slowdown.
6:55 p.m. Sept. 24, 2020 - By MarketWatch
‘Open letter to America’ signed by 489 national-security leaders calls Trump ‘not equal to the enormous responsibilities of his office’ Former Vice President Joe Biden, the Democratic presidential nominee, ‘is, above all, a good man with a strong sense of right and wrong,’ states letter from retired generals, admirals, NCOs, ambassadors and national-security officialsFormer Vice President Joe Biden, the Democratic presidential nominee, ‘is, above all, a good man with a strong sense of right and wrong,’ the letter states.
7:40 p.m. Sept. 22, 2020 - Associated Press
Congressional watchdog GAO faults IRS and Treasury Department for millions of missing pandemic relief checks GAO report also faults CDC over school-reopening guidelinesGovernment Accounting Office’s report also faults Centers for Disease Control and Prevention over school-reopening guidelines.
5:25 p.m. Sept. 21, 2020 - Associated Press
CDC says retracted posting that appeared to change the agency’s position on the aerosolized spread of coronavirus was ‘an honest mistake’ Centers for Disease Control and Prevention reportedly acted after CNN took note of the changed language about viral transmissionCenters for Disease Control and Prevention reportedly acted after CNN took note of the changed language about viral transmission.
12:21 a.m. Sept. 20, 2020 - By Andrew Keshner
Federal law now gives some parents paid time off to help their kids with remote learning Worried about missing work if your child’s school suddenly closes? You may be eligible for paid time offWorried about missing work if your child’s school suddenly closes? You may be eligible for paid time off.
11:29 a.m. Sept. 18, 2020 - By Ciara Linnane
Coronavirus update: Global case tally tops 30 million, and controversial CDC testing guideline changes were reportedly not made by CDC scientists HHS revised the guidelines to say asymptomatic patients don’t need testing and then ‘dropped’ them on CDC site without vetting, New York Times reportsThe number of confirmed cases of the coronavirus that causes COVID-19 rose above 30 million on Friday, and the death toll rose above 946,000, with the U.S. death toll edging closer to 200,000, or almost a fifth of the global tally.
7:00 p.m. Sept. 17, 2020 - By Mike Murphy
CDC didn't write or approve changes to coronavirus testing guidelines: reportControversial coronavirus-testing guidelines posted on the CDC website that said asymptomatic people don't need to get tested even if they have been exposed to the virus were not actually written by the CDC, Thursday, and were posted over the objections of CDC scientists. Citing internal documents and sources familiar with the matter, the Times said the Department of Health and Human Services rewrote the testing guidelines and "dropped" them into the CDC's website without proper vetting. The recommendation contained numerous errors, the Times reported, and was inconsistent with the CDC's messaging, especially as asymptomatic people are considered major vectors of COVID-19's spread. The Centers for Disease Control and Prevention quickly after an uproar. A new version of testing guidelines is expected to be announced Friday, the Times said, which also has been revised by the HHS and has apparently not been properly vetted. The incident appears to be yet another instance of the politicalization of an historically apolitical agency, which threatens to undermine its credibility during the worst pandemic in a century.
11:05 a.m. Sept. 17, 2020 - By Ciara Linnane
Coronavirus update: Global cases near 30 million; Trump contradicts CDC head on vaccine timetable and again derides face masks WHO official says it’s important to have ‘consistent messaging’ on pandemic from all public officials The number of confirmed cases of the coronavirus that causes COVID-19 worldwide continued to head toward 30 million on Thursday, and the U.S. case tally climbed above 6.6 million, as President Donald Trump contradicted the head of the main U.S. public health agency to insist a vaccine would be ready in weeks.
4:06 a.m. Sept. 17, 2020 - Associated Press
Medicare administrator Verma said to have paid private consultants nearly $6 million in taxpayer money for personal image-building campaign The consultants, many with Republican ties, billed taxpayers up to $380 per hour for work largely aimed at polishing the profile of Medicare administrator Seema Verma, say congressional investigatorsThe consultants, many with Republican Party ties, billed taxpayers up to $380 per hour on work largely aimed at polishing the profile of Medicare administrator Seema Verma, congressional investigators write.
1:42 p.m. Sept. 16, 2020 - Associated Press
Coronavirus vaccine likely to be unavailable to most Americans until well into 2021 CDC chief adds wearing masks may be better protection than eventual vaccine The government outlined a sweeping plan Wednesday to make vaccines for COVID-19 available for free to all Americans when proven safe and effective, though a top public health official made clear that widespread vaccination of millions of Americans couldn’t come until well into next year.
9:25 a.m. Sept. 16, 2020 - By Robert Schroeder
Trump health official Caputo to take leave of absence after blasting government scientistsMichael Caputo, the assistant secretary of health for public affairs, will take a 60-day leave of absence "to focus on his health and the well-being of his family," a statement from the Department of Health and Human Services said. Caputo of trying to muzzle an important scientific report in the midst of the coronavirus pandemic, and apologized Tuesday for a separate video in which he reportedly says scientists battling the virus are conspiring against President Donald Trump. HHS also said Dr. Paul Alexander, who to alter a key CDC report, is leaving the department.
9:19 a.m. Sept. 16, 2020 - By Ciara Linnane
Coronavirus update: Global cases edge toward 30 million; Trump denies playing down crisis, says U.S. will have ‘herd mentality’ Trump blames presidential opponent Joe Biden for failing to implement a face mask mandateThe number of confirmed cases of the coronavirus that causes COVID-19 moved closer to 30 million on Wednesday, and the U.S. tally rose to 6.6 million, as President Donald Trump denied that he had played down the virus, even though he admitted as much in a taped recording released last week.
Browse topics:

Filter results by

Industry

Health-care (78)

Pharmaceuticals (24)

Media (23)

Medical Products (22)

Biotechnology (18)

Software (16)

Location

Us (118)

Asia Pacific (24)

China (24)

Europe (21)

Eu (19)

Latin America (5)

Link to MarketWatch's Slice.